200 related articles for article (PubMed ID: 35249533)
1. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer.
Liu S; Peng X; Wu X; Bu F; Yu Z; Zhu J; Luo C; Zhang W; Liu J; Huang J
World J Surg Oncol; 2022 Mar; 20(1):71. PubMed ID: 35249533
[TBL] [Abstract][Full Text] [Related]
2. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
Xu M; Li Q; Zhang J; Xie H
Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
[TBL] [Abstract][Full Text] [Related]
4. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
5. Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer.
Xue Y; Ning B; Liu H; Jia B
BMC Gastroenterol; 2022 Mar; 22(1):127. PubMed ID: 35300596
[TBL] [Abstract][Full Text] [Related]
6. Constructing a prognostic immune-related lncRNA model for colon cancer.
Li X; Yang L; Wang W; Rao X; Lai Y
Medicine (Baltimore); 2022 Sep; 101(38):e30447. PubMed ID: 36197160
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel immune-related long noncoding RNA signature to predict the prognosis of bladder cancer.
Ren W; Zuo S; Yang L; Tu R; Wang P; Zhang X
Sci Rep; 2022 Mar; 12(1):3444. PubMed ID: 35236887
[TBL] [Abstract][Full Text] [Related]
8. Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients.
Li Z; Wei J; Zheng H; Gan X; Song M; Zhang Y; Jin Y
Medicine (Baltimore); 2022 Jan; 101(1):e28531. PubMed ID: 35029920
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
Qi X; Chen G; Chen Z; Li J; Chen W; Lin J; Lin L
Int J Gen Med; 2021; 14():4279-4289. PubMed ID: 34421308
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features.
Lei Y; Tang R; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Wang W; Shi S
Bioengineered; 2021 Dec; 12(1):3593-3602. PubMed ID: 34238114
[TBL] [Abstract][Full Text] [Related]
11. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
Wang Y; Zhang X; Dai X; He D
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
[No Abstract] [Full Text] [Related]
12. Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma.
Yin J; Li X; Lv C; He X; Luo X; Li S; Hu W
Front Mol Biosci; 2021; 8():689224. PubMed ID: 34327215
[No Abstract] [Full Text] [Related]
13. Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma.
Wang G; Liu P; Li J; Jin K; Zheng X; Xie L
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891325
[TBL] [Abstract][Full Text] [Related]
14. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X
Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851
[TBL] [Abstract][Full Text] [Related]
15. Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer.
Wang X; Chen K; Wang Z; Xu Y; Dai L; Bai T; Chen B; Yang W; Chen W
Front Cell Dev Biol; 2021; 9():750709. PubMed ID: 34660608
[No Abstract] [Full Text] [Related]
16. An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer.
Hou J; Liang S; Xie Z; Qu G; Xu Y; Yang G; Tang C
Sci Rep; 2022 Feb; 12(1):3225. PubMed ID: 35217715
[TBL] [Abstract][Full Text] [Related]
17. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma.
Hong W; Liang L; Gu Y; Qi Z; Qiu H; Yang X; Zeng W; Ma L; Xie J
Mol Ther Nucleic Acids; 2020 Dec; 22():937-947. PubMed ID: 33251044
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel immune-related lncRNA signature to predict prognostic outcome and therapeutic efficacy of LGG.
Wu D; Wang X; Xue Y; Sun C; Zhang M
J Integr Neurosci; 2022 Mar; 21(2):55. PubMed ID: 35364643
[TBL] [Abstract][Full Text] [Related]
20. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
